ETF MANAGERS GROUP, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
ETF MANAGERS GROUP, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2023$148,386
-11.1%
9,004
-29.9%
0.01%0.0%
Q3 2022$167,000
-7.2%
12,846
-1.0%
0.01%0.0%
Q2 2022$180,000
-20.4%
12,974
-17.2%
0.01%0.0%
Q1 2022$226,000
-41.5%
15,660
-44.9%
0.01%
-37.5%
Q4 2021$386,000
-21.2%
28,417
-5.5%
0.01%
-11.1%
Q3 2021$490,000
+34.2%
30,065
+38.5%
0.01%
+50.0%
Q2 2021$365,000
-4.2%
21,703
+4.5%
0.01%
-14.3%
Q1 2021$381,000
+3.0%
20,773
+2.0%
0.01%
-12.5%
Q4 2020$370,000
+5.7%
20,368
+5.6%
0.01%
-27.3%
Q3 2020$350,000
+167.2%
19,297
+166.3%
0.01%
+120.0%
Q2 2020$131,0007,2450.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders